Bertha Knoll
Semmelweis University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bertha Knoll.
Physiology & Behavior | 1996
Julia Timár; Zsuzsanna Gyarmati; László Barna; Bertha Knoll
Effects of deprenyl and amphetamine enantiomers on different behavioural patterns were compared. Whereas (+)-amphetamine in doses of 1-3 mg/kg SC, (-)-amphetamine, and (+)-deprenyl in doses of 5-20 mg/kg SC increased the locomotor activity and the time the animals displayed stereotyped head movement, enhanced the acquisition of conditioned avoidance responses, and developed positive place preference conditioning, (-)-deprenyl, even in as high a dose as 20 mg/kg SC, failed to show any amphetamine-type behavioural effect. The results provide further proof why (-)-deprenyl, in contrast to other members of the amphetamine family, can be considered as a safe drug.
Physiology & Behavior | 1985
Susanna Gyarmati; J. Földes; L. Korányi; Bertha Knoll; J. Knoll
The effect of satietin and amphetamine on the carbohydrate metabolism of free fed and food deprived rats was studied. Rats deprived of food for 96 hours maintained normal glucose and glucagon blood levels but the blood concentration of insulin dropped from 232.02 +/- 23.93 to 12.48 +/- 0.71 pmol/l. Amphetamine (500 micrograms/animal, intracerebroventricularly) left in normally fed rats the blood concentration of glucose, insulin and glucagon unchanged. The same treatment, however, increased the insulin concentration in the blood of food deprived rats from 11.37 +/- 4.43 to 73.47 +/- 8.29 pmol/l. Glucose and glucagon, as well as insulin levels remained unchanged in both normally fed and food deprived rats when treated with satietin (20 micrograms/rat, intracerebroventricularly). It was concluded that the anorectic effect of satietin is unrelated to carbohydrate metabolism.
Catecholamines: Basic and Clinical Frontiers#R##N#Proceedings of the Fourth International Catecholamine Symposium, Pacific Grove, California, September 17-22, 1978 | 1979
Bertha Knoll; Julia Timár
Clorgyline, the selective inhibitor of MAO A counteracts the effect of the substantia nigra (SN) lesion, while (-)deprenyl, the selective inhibitor of MAO B proved to be ineffective showing that type A is the functionally important form of MAO in the nigrostriatal dopaminergic neurons of rat.
Synaptic Constituents in Health and Disease#R##N#Proceedings of the Third Meeting of the European Society for Neurochemistry, Bled, August 31st to September 5th, 1980 | 1980
Bertha Knoll; H. Kalász
Publisher Summary This chapter focuses a substance named satietin that is capable of reducing food intake drastically in rats deprived of food for 96 h, which was discovered in human serum and detected in the blood of different species. Highly purified satietin samples extracted from human serum showing one band only in polyacrylamide gelelectrophoresis, containing in average 60.6% amino acids and 13.5% carbohydrates, were used for biological experiments. The intracerebroventricular injection of 10–100 μg satietin 5 h before the test meal decreased food consumption drastically and in a dose-dependent manner. The satietin-like long lasting inhibition of food intake seems to be unique.
Archives internationales de pharmacodynamie et de thérapie | 1992
Bertha Knoll; Török Z; Julia Timár; Yasar S
Archives internationales de pharmacodynamie et de thérapie | 1986
Julia Timár; Bertha Knoll
Acta Physiologica Hungarica | 1992
Julia Timár; Bertha Knoll
European Journal of Pharmacology | 1990
Bertha Knoll; Yasar S; I. Faragó; Illés Kovács
Monoamine Oxidases and their Selective Inhibition#R##N#Proceedings of the 3rd Congress of the Hungarian Pharmacological Society, Budapest, 1979 | 1980
Bertha Knoll
Pharmacological Research | 1995
Julia Timár; S. Gyarmati; L. Barna; Bertha Knoll